Average Co-Inventor Count = 4.00
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (11 from 4,177 patents)
2. Northwestern University (4 from 2,112 patents)
3. Other (2 from 832,680 patents)
4. University of Nebraska (2 from 730 patents)
17 patents:
1. 11261237 - Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
2. 11207423 - Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
3. 10583199 - Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
4. 10081668 - Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
5. 7491718 - Sulfonamides having antiangiogenic and anticancer activity
6. 7432245 - Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
7. 7030262 - 3-Amino-2-hydroxyalkanoic acids and their prodrugs
8. 6849757 - Antiangiogenic drug to treat cancer, arthritis and retinopathy
9. 6777535 - N-alkylated peptides having antiangiogenic activity
10. 6774211 - Peptide antiangiogenic drugs
11. 6753408 - Peptides having antiangiogenic activity
12. 6716963 - Peptide antiangiogenic drugs
13. 6632961 - Antiangiogenic drug to treat cancer, arthritis and retinopathy
14. 6288228 - Triazine angiogenesis inhibitors
15. 6242494 - Substituted &bgr;-amino acid inhibitors of methionine aminopeptidase-2